SBIR: Evaluation of the Therapeutic Potential of Exclusive Antagonists of Extrasynaptic NMDA Receptors for Treatment of Opioid Use Disorder

Grants and Contracts Details

StatusFinished
Effective start/end date9/30/19 → 8/31/20

Funding

  • Neurano Bioscience: $114,999.00